Do all young ischemic stroke patients need long-term secondary preventive medication?

Neurology. 2005 Aug 23;65(4):609-11. doi: 10.1212/01.wnl.0000173029.89752.7b.

Abstract

After a mean of 6 years, the frequencies of later vascular events (recurrent ischemic stroke or myocardial infarction) in 232 young ischemic stroke patients (younger than 50 years) with none to five traditional risk factors were 2.1%, 6%, 19%, 26%, 30%, and 67% (p < 0.001). Long-term secondary preventive medication may not be indicated in young ischemic stroke patients with no risk factor.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Anticoagulants / therapeutic use
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / epidemiology
  • Brain Ischemia / prevention & control*
  • Drug Administration Schedule
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / prevention & control
  • Norway / epidemiology
  • Retrospective Studies
  • Risk Factors
  • Secondary Prevention
  • Stroke / drug therapy*
  • Stroke / epidemiology
  • Stroke / prevention & control*
  • Tomography, X-Ray Computed

Substances

  • Anticoagulants